NCT02145559View on ClinicalTrials.gov

A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 15, 2016

Study Completion Date

July 31, 2018

Conditions
Breast NeoplasmsLung NeoplasmsCancer of LiverLymphomaCancer of Kidney
Interventions
DRUG

Metformin XR

DRUG

Delayed Metformin

DRUG

Sirolimus

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT02145559 - A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter